Latest News

Intranasal ketamine confers rapid antidepressant effect in depression

The first controlled evidence has been released showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect ?- within 24 hours ?- and was well tolerated in patients with treatment-resistant major depressive disorder. One of the most common NMDA receptor antagonists, ketamine is an FDA-approved anesthetic. It has been used in animals and humans for years. Ketamine has also been a drug of abuse and can lead to untoward psychiatric or cognitive problems when misused. In low doses, ketamine shows promise in providing rapid relief of depression, with tolerable side effects.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Why don't genetically identical cells behave identically? Cellular noise

  • Metastatic brain tumor treatment could be on the horizon with use of SapC-DOPS

  • Protein couple controls flow of information into brain's memory center

  • How stress hormones promote brain's building of negative memories

  • Increased levels of the body's own cannabinoids impair embryonic brain development

  • Rigid connections: Molecular basis of age-related memory loss explained

  • Low strength brain stimulation may be effective for depression

  • Neuroprotective role of immune cell discovered

  • Enzyme linked to Alzheimer?s disease

  • Epigenetic tie to neuropsychiatric disorders found

  •